Close Menu

NEW YORK – Fluxion Biosciences said today that the National Institutes of Health awarded the firm a $284,132 Phase I research grant in September to develop its Spotlight non-invasive prenatal test. 

As part of the project, the Alameda, California-based firm will validate a model system for test development, integrate key test components, and conduct clinical testing to compare Spotlight NIPT performance to competitive NIPT screening assays. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.